Healthtech funding in Q1 2026
European Healthtech startup funding raised during Q1 2026.
In Q1 2026, 132 European Healthtech companies closed 133 funding rounds and raised €1.4B in equity funding (excluding debt and grants), down 45.0% versus Q1 2025. Debt rounds added €149M. UK led by capital raised, and BioInnovation Institute was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.4B
-45.0% vs Q1 2025 · excl. debt & grants · +€149M debt
Funding rounds
133
+18.8% vs Q1 2025
Companies
132
Top country
UK
Rank among sectors
#5
6.7% of sector funding
Debt financing
€149M
9.4% of total
Top-10 round share
45.9%
of disclosed capital
Rounds ≥ €100M
2
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q1 2026 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €850M | 51 |
| Feb | €446M | 40 |
| Mar | €279M | 42 |
Top countries
by € raisedHealthtech — top countries by capital, Q1 2026 — interactive chart.
Data table
| Healthtech — top countries by capital, Q1 2026 | |
|---|---|
| UK | €491M |
| France | €240M |
| Germany | €201M |
| Netherlands | €146M |
| Ireland | €114M |
| Iceland | €100M |
| Switzerland | €82M |
| Spain | €71M |
Stage mix
by € raisedHealthtech — stage mix, Q1 2026 — interactive chart.
Data table
| Healthtech — stage mix, Q1 2026 | |
|---|---|
| Other | €431M |
| Series A | €285M |
| Series D+ | €211M |
| Series C | €194M |
| Series B | €162M |
| Debt | €149M |
| Seed | €74M |
| Grant | €56M |
| Pre-Seed | €7.4M |
| Growth/Late | €5.8M |
Exits & M&A
8 Acquisition8 exits · €469M disclosed.
| Kaia Health | Acquisition | Jan 2026 | €239M |
| Gleamer | Acquisition | Mar 2026 | €230M |
Top deals
largest disclosed rounds in Q1 2026| Company | Stage | Date | Amount |
|---|---|---|---|
| Oviva | Series D+ | Jan 2026 | €200M |
| Alvotech | Debt | Jan 2026 | €100M |
| DentalMonitoring | Other | Feb 2026 | €71M |
| Neurent Medical | Series C | Feb 2026 | €63M |
| Vitestro | Series B | Mar 2026 | €60M |
| Exciva | Series B | Jan 2026 | €51M |
| FineHeart | Grant | Jan 2026 | €48M |
| Biorce | Series A | Feb 2026 | €44M |
| Polares Medical | Series C | Mar 2026 | €43M |
| bit.bio | Other | Jan 2026 | €43M |
| Automata Technologies | Series C | Jan 2026 | €38M |
| Recare Solutions | Other | Jan 2026 | €37M |
| FineHeart | Series C | Jan 2026 | €35M |
| Centauri | Series A | Feb 2026 | €34M |
| Aerska | Series A | Feb 2026 | €33M |
Top investors
most active in Q1 2026, by deal count- BioInnovation Institute6 deals
- High-Tech Gründerfonds (HTGF)5 deals
- BioInnovation Institute (BII)3 deals
- EIC Accelerator3 deals
- Empirical Ventures3 deals
- European Investment Bank (EIB)3 deals
- InnoBooster program3 deals
- Innovate UK3 deals
- TÜBİTAK BIGG Fund3 deals
- amberra2 deals